To me this is really shaping up like a replica of IMU.Licensing...

To me this is really shaping up like a replica of IMU.
Licensing the best future IP you can, then bring in the best managing, and expert's from around the world, that have left there positions from the best company's and research facility's to join this little ossie biotech. I'm sure they would not be risking there reputation's if they were not confident.
NK platform to boot, gives them plenty of chances and not just relying on one shot. Just like IMU they will have multiple partners down the track.
Picked up another 100k today, any thing under 30 cents is going to look pretty cheap in a couple of years in IMO.
87 Mill market cap, looking at a minimum 10 bags in the long run, but probably more if the NK works.
As I have said, these expert's from all around the world are not joining the company for nothing. plus director buying on market at 34cents gives you an idea.
glta.